• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非手术治疗 Peyronie 病。

Nonsurgical management of Peyronie's disease.

机构信息

Rush University Medical Center, Chicago, IL, USA.

出版信息

Nat Rev Urol. 2019 Mar;16(3):172-186. doi: 10.1038/s41585-018-0117-7.

DOI:10.1038/s41585-018-0117-7
PMID:30397330
Abstract

Peyronie's disease is not a rare disorder, and it can be devastating to the affected man. Although the gold-standard treatment of Peyronie's disease is surgery in the stable phase, nonoperative management is preferred by some men and is the only treatment option in the acute phase of the disease, when surgery is contraindicated. No oral or topical therapy has been shown to be efficacious when administered alone, but some evidence supports their use as part of a combination therapy regimen. Intralesional therapies, particularly collagenase clostridium histolyticum (CCH), have shown promise. Mechanical therapies can provide benefit when applied for prolonged periods of time, improving penile curvature, indentation, and even restoring length. Regardless of the modality chosen, patient counselling is paramount, as recovery of the penis to its predisease state is highly unlikely. Thus, although many options exist for nonsurgical management of Peyronie's disease, surgery remains the best option for men who desire the most reliable and rapid pathway to a functionally straight, erect penis. The goal of nonsurgical therapy should be a scientifically feasible, safe approach to prevent the progression of, or reduce, deformity and improve sexual function.

摘要

佩罗尼病并不罕见,它可能对受影响的男性造成毁灭性的打击。虽然佩罗尼病的金标准治疗方法是稳定期的手术,但一些男性更喜欢非手术治疗,而且在手术禁忌的疾病急性期,这是唯一的治疗选择。单独使用时,没有口服或局部治疗被证明是有效的,但有一些证据支持将其作为联合治疗方案的一部分使用。腔内治疗,特别是胶原酶溶组织梭菌(CCH),显示出了希望。机械治疗在长时间应用时可以提供益处,改善阴茎弯曲、凹陷,甚至恢复长度。无论选择哪种治疗方式,患者咨询都是至关重要的,因为恢复到疾病前的阴茎状态的可能性非常低。因此,尽管存在许多非手术治疗佩罗尼病的选择,但对于那些希望通过最可靠和最快的途径获得功能正常、直立的阴茎的男性来说,手术仍然是最佳选择。非手术治疗的目标应该是一种科学可行、安全的方法,以预防或减少畸形并改善性功能。

相似文献

1
Nonsurgical management of Peyronie's disease.非手术治疗 Peyronie 病。
Nat Rev Urol. 2019 Mar;16(3):172-186. doi: 10.1038/s41585-018-0117-7.
2
Surgical correction of persistent Peyronie's disease following collagenase clostridium histolyticum treatment.溶组织梭状芽孢杆菌胶原酶治疗后持续性佩罗尼氏病的手术矫正
J Sex Med. 2015 Jan;12(1):259-64. doi: 10.1111/jsm.12721. Epub 2014 Oct 27.
3
Treatment of Peyronie's Disease With Collagenase Clostridium histolyticum and Vacuum Therapy: A Randomized, Open-Label Pilot Study.采用胶原酶组织溶菌素和真空疗法治疗 Peyronie 病:一项随机、开放标签的初步研究。
J Sex Med. 2017 Nov;14(11):1430-1437. doi: 10.1016/j.jsxm.2017.08.015. Epub 2017 Sep 30.
4
Clinical safety and effectiveness of collagenase clostridium histolyticum injection in patients with Peyronie's disease: a phase 3 open-label study.溶组织梭状芽孢杆菌胶原酶注射治疗佩罗尼氏病患者的临床安全性和有效性:一项3期开放标签研究。
J Sex Med. 2015 Jan;12(1):248-58. doi: 10.1111/jsm.12731. Epub 2014 Nov 12.
5
Review of Intralesional Collagenase Clostridium Histolyticum Injection Therapy and Related Combination Therapies in the Treatment of Peyronie's Disease (an Update).病灶内注射溶组织梭状芽孢杆菌胶原酶治疗佩罗尼氏病及相关联合疗法的综述(更新版)
Sex Med Rev. 2021 Apr;9(2):340-349. doi: 10.1016/j.sxmr.2020.01.005. Epub 2020 Mar 18.
6
Review of Management Options for Active-Phase Peyronie's Disease.主动相 Peyronie 病的治疗选择综述。
Sex Med Rev. 2019 Apr;7(2):329-337. doi: 10.1016/j.sxmr.2018.09.007. Epub 2018 Nov 30.
7
Sildenafil 25 mg ODT + Collagenase Clostridium hystoliticum vs Collagenase Clostridium hystoliticum Alone for the Management of Peyronie's Disease: A Matched-Pair Comparison Analysis.西地那非 25 毫克口腔崩解片+胶原酶梭菌组织溶解酶与单独使用胶原酶梭菌组织溶解酶治疗阴茎硬结症的比较:配对比较分析。
J Sex Med. 2018 Oct;15(10):1472-1477. doi: 10.1016/j.jsxm.2018.08.012. Epub 2018 Sep 20.
8
Safety and Efficacy of Collagenase Clostridium histolyticum in the Treatment of Acute-Phase Peyronie's Disease.胶原酶注射治疗急性期 Peyronie 病的安全性和疗效。
J Sex Med. 2017 Oct;14(10):1220-1225. doi: 10.1016/j.jsxm.2017.08.008. Epub 2017 Sep 2.
9
Collagenase Clostridium histolyticum in the Treatment of Peyronie's Disease-A Review of the Literature and a New Modified Protocol.胶原酶溶组织梭菌在治疗 Peyronie 病中的应用——文献回顾和新的改良方案。
Sex Med Rev. 2017 Oct;5(4):529-535. doi: 10.1016/j.sxmr.2017.07.005. Epub 2017 Sep 2.
10
Comparative Cost-effectiveness of Surgery, Collagenase Clostridium Histolyticum, and Penile Traction Therapy in Men with Peyronie's Disease in an Era of Effective Clinical Treatment.在有效的临床治疗时代,阴茎硬结症男性患者中手术、胶原酶注射与阴茎牵引治疗的成本效果比较。
J Sex Med. 2019 Sep;16(9):1421-1432. doi: 10.1016/j.jsxm.2019.06.010. Epub 2019 Jul 24.

引用本文的文献

1
Measurement of Oxidative Stress Index in 102 Patients with Peyronie's Disease.102例佩罗尼氏病患者氧化应激指数的测量
Metabolites. 2025 Jul 29;15(8):503. doi: 10.3390/metabo15080503.
2
A novel autologous material for the surgical treatment of Peyronie's disease: the outer plate of the prepuce.一种用于佩罗尼氏病手术治疗的新型自体材料:包皮外板。
Transl Androl Urol. 2025 Jun 30;14(6):1566-1574. doi: 10.21037/tau-2025-200. Epub 2025 Jun 24.
3
Current and Future Directions of Technology in Assessment of Peyronie's Disease.当前和未来技术在评估佩罗尼病中的应用方向。
Curr Urol Rep. 2024 Oct 29;26(1):15. doi: 10.1007/s11934-024-01247-z.
4
Measurement of Oxidative Stress Index (OSI) in Penile Corpora Cavernosa and Peripheral Blood of Peyronie's Disease Patients: A Report of 49 Cases.佩罗尼氏病患者阴茎海绵体和外周血中氧化应激指数(OSI)的测量:49例报告
Metabolites. 2024 Jan 15;14(1):55. doi: 10.3390/metabo14010055.
5
Is there a new role for oral therapy to treat peyronie's disease? Commentary on Daily low-dose tadalafil may reduce the penile curvature progression rate in patients with acute Peyronie's Disease: a retrospective comparative analysis.口服疗法在治疗佩罗尼氏病方面是否有新作用?对《每日小剂量他达拉非可能降低急性佩罗尼氏病患者阴茎弯曲进展率:一项回顾性对比分析》的评论
Int J Impot Res. 2024 Apr;36(2):160-161. doi: 10.1038/s41443-023-00684-7. Epub 2023 Feb 24.
6
The Application of Hyaluronic Acid Injections in Functional and Aesthetic Andrology: A Narrative Review.透明质酸注射在功能与美学男科学中的应用:一项叙述性综述
Gels. 2023 Feb 1;9(2):118. doi: 10.3390/gels9020118.
7
The efficacy and safety of intralesional injection of collagenase for Peyronie's disease: A meta-analysis of published prospective studies.病灶内注射胶原酶治疗佩罗尼氏病的疗效与安全性:已发表前瞻性研究的荟萃分析
Front Pharmacol. 2022 Oct 5;13:973394. doi: 10.3389/fphar.2022.973394. eCollection 2022.
8
Efficacy and Safety of Collagenase Clostridium Histolyticum in the Treatment of Peyronie's Disease: An Evidence-Based Analysis.溶组织梭菌胶原酶治疗佩罗尼氏病的疗效与安全性:一项循证分析
Front Med (Lausanne). 2022 Feb 18;9:780956. doi: 10.3389/fmed.2022.780956. eCollection 2022.
9
The collagenase of the bacterium Clostridium histolyticum does not favor metastasis of breast cancer.溶组织梭菌胶原酶并不促进乳腺癌转移。
Breast Cancer. 2022 Jul;29(4):599-609. doi: 10.1007/s12282-022-01337-1. Epub 2022 Feb 7.
10
Molecular Mechanisms and Current Pharmacotherapy of Peyronie's Disease: A Review.佩罗尼氏病的分子机制与当前药物治疗:综述
Front Pharmacol. 2021 May 20;12:643641. doi: 10.3389/fphar.2021.643641. eCollection 2021.